Author:
Liu Xin,Jin Yongzeng,Cheng Xinyi,Song Qinghua,Wang Yanan,He Ling,Chen Tong
Funder
National Natural Science Foundation of China
“Double First-Class” University project
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Bailly M, Ribeiro MJ, Vercouillie J, Hommet C, Gissot V, Camus V, Guilloteau D (2015) 18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease. Clin Nucl Med 40:e111–e116
2. Barrier L, Fauconneau B, Noël A, Ingrand S (2010) Ceramide and related-sphingolipid levels are not altered in disease-associated brain regions of APP and APP/PS1 Mouse models of Alzheimer’s disease: relationship with the lack of neurodegeneration? Int J Alzheimers Dis 2011:920958
3. Barthélemy NR, Horie K, Sato C, Bateman RJ (2020) Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease. J Exp Med 217(11):e20200861
4. Ben-David O, Futerman AH (2010) The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. NeuroMol Med 12:341–350
5. Boden G, She P, Mozzoli M, Cheung P, Gumireddy K, Reddy P, Xiang X, Luo Z, Ruderman N (2005) Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes 54:3458–3465
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献